NAMs – including Organ-on-Chip, organoids, digital twins, and bioprinting – offer innovative, animal-free testing methods. However, regulatory barriers, insufficient infrastructure, and knowledge gaps hinder their widespread application. STEP4NAMs aims to change that.

During the meeting, key objectives were defined:

• Developing a joint strategy to promote NAMs
• Conducting four pilot studies to validate best practices
• Creating a NAM validation handbook for researchers and developers
• Establishing a training and support program for stakeholders

We look forward to the next steps and to actively driving the adoption of NAMs forward!